Deciphering the Elevated Lipid via CD36 in Mantle Cell Lymphoma with Bortezomib Resistance Using Synchrotron-Based Fourier Transform Infrared Spectroscopy of Single Cells

Despite overall progress in improving cancer treatments, the complete response of mantle cell lymphoma (MCL) is still limited due to the inevitable development of drug resistance. More than half of patients did not attain response to bortezomib (BTZ), the approved treatment for relapsed or refractor...

Descripción completa

Detalles Bibliográficos
Autores principales: Luanpitpong, Sudjit, Janan, Montira, Thumanu, Kanjana, Poohadsuan, Jirarat, Rodboon, Napachai, Klaihmon, Phatchanat, Issaragrisil, Surapol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521097/
https://www.ncbi.nlm.nih.gov/pubmed/31022903
http://dx.doi.org/10.3390/cancers11040576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521097/
https://www.ncbi.nlm.nih.gov/pubmed/31022903
http://dx.doi.org/10.3390/cancers11040576

Ejemplares similares